JP2015508403A5 - - Google Patents

Download PDF

Info

Publication number
JP2015508403A5
JP2015508403A5 JP2014550739A JP2014550739A JP2015508403A5 JP 2015508403 A5 JP2015508403 A5 JP 2015508403A5 JP 2014550739 A JP2014550739 A JP 2014550739A JP 2014550739 A JP2014550739 A JP 2014550739A JP 2015508403 A5 JP2015508403 A5 JP 2015508403A5
Authority
JP
Japan
Prior art keywords
collagen
aging
temperature
step comprises
dehydrated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014550739A
Other languages
English (en)
Japanese (ja)
Other versions
JP6494285B2 (ja
JP2015508403A (ja
Filing date
Publication date
Priority claimed from EP20120150527 external-priority patent/EP2612888A1/en
Priority claimed from GBGB1220868.2A external-priority patent/GB201220868D0/en
Application filed filed Critical
Priority claimed from PCT/EP2013/050333 external-priority patent/WO2013104687A2/en
Publication of JP2015508403A publication Critical patent/JP2015508403A/ja
Publication of JP2015508403A5 publication Critical patent/JP2015508403A5/ja
Application granted granted Critical
Publication of JP6494285B2 publication Critical patent/JP6494285B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014550739A 2012-01-09 2013-01-09 変性コラーゲン Expired - Fee Related JP6494285B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20120150527 EP2612888A1 (en) 2012-01-09 2012-01-09 A modified collagen
EP12150527.5 2012-01-09
GBGB1220868.2A GB201220868D0 (en) 2012-11-20 2012-11-20 A modified collagen
GB1220868.2 2012-11-20
PCT/EP2013/050333 WO2013104687A2 (en) 2012-01-09 2013-01-09 A modified collagen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018223061A Division JP6720279B2 (ja) 2012-01-09 2018-11-29 変性コラーゲン

Publications (3)

Publication Number Publication Date
JP2015508403A JP2015508403A (ja) 2015-03-19
JP2015508403A5 true JP2015508403A5 (cg-RX-API-DMAC7.html) 2016-03-17
JP6494285B2 JP6494285B2 (ja) 2019-04-03

Family

ID=47559477

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014550739A Expired - Fee Related JP6494285B2 (ja) 2012-01-09 2013-01-09 変性コラーゲン
JP2018223061A Expired - Fee Related JP6720279B2 (ja) 2012-01-09 2018-11-29 変性コラーゲン
JP2020104510A Active JP7213205B2 (ja) 2012-01-09 2020-06-17 変性コラーゲン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018223061A Expired - Fee Related JP6720279B2 (ja) 2012-01-09 2018-11-29 変性コラーゲン
JP2020104510A Active JP7213205B2 (ja) 2012-01-09 2020-06-17 変性コラーゲン

Country Status (22)

Country Link
US (4) US10487134B2 (cg-RX-API-DMAC7.html)
EP (4) EP2802624B1 (cg-RX-API-DMAC7.html)
JP (3) JP6494285B2 (cg-RX-API-DMAC7.html)
AU (1) AU2013208952B2 (cg-RX-API-DMAC7.html)
CA (1) CA2860552C (cg-RX-API-DMAC7.html)
CY (3) CY1119524T1 (cg-RX-API-DMAC7.html)
DK (3) DK3255106T3 (cg-RX-API-DMAC7.html)
EA (2) EA037396B1 (cg-RX-API-DMAC7.html)
ES (3) ES2728205T3 (cg-RX-API-DMAC7.html)
HK (1) HK1244296B (cg-RX-API-DMAC7.html)
HR (3) HRP20171635T1 (cg-RX-API-DMAC7.html)
HU (3) HUE054838T2 (cg-RX-API-DMAC7.html)
LT (3) LT2802624T (cg-RX-API-DMAC7.html)
MX (1) MX368037B (cg-RX-API-DMAC7.html)
NO (1) NO2802624T3 (cg-RX-API-DMAC7.html)
PL (3) PL3255106T3 (cg-RX-API-DMAC7.html)
PT (2) PT3255106T (cg-RX-API-DMAC7.html)
RS (3) RS58935B1 (cg-RX-API-DMAC7.html)
SI (3) SI3255106T1 (cg-RX-API-DMAC7.html)
SM (3) SMT202100257T1 (cg-RX-API-DMAC7.html)
TR (1) TR201907156T4 (cg-RX-API-DMAC7.html)
WO (1) WO2013104687A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE054838T2 (hu) * 2012-01-09 2021-10-28 Innocoll Pharm Ltd Módosított kollagén
US20180237259A1 (en) * 2017-02-22 2018-08-23 Otis Elevator Company Method for detecting trapped passengers in elevator car
RU2704248C1 (ru) * 2018-10-02 2019-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") Способ получения пористого коллагенового материала
RU2760326C1 (ru) * 2021-03-04 2021-11-24 Общество с ограниченной ответственностью научно-производственное объединение «Велис» Способ получения пористого влагоемкого материала на коллагеновой основе
US20240226382A1 (en) 2021-04-12 2024-07-11 Innocoll Pharmaceuticals Limited Drug-release implant for laparoscopic surgery
CN113201569B (zh) * 2021-06-21 2022-08-30 江南大学 一种牛ⅰ型胶原蛋白的纯化方法
EP4376806A2 (en) * 2021-07-28 2024-06-05 Innocoll Pharmaceuticals Limited Bupivacaine-collagen drug delivery implant and methods of making and using thereof
WO2023084005A1 (en) * 2021-11-12 2023-05-19 Innocoll Pharmaceuticals Limited Resorbable collagen scaffold for dural repair
WO2024079289A1 (en) 2022-10-12 2024-04-18 Innocoll Pharmaceuticals Limited A kit for implanting a drug-release implant for laparoscopic surgery
CN115975247B (zh) 2022-12-21 2024-01-30 合肥工业大学 一种抗生物污损的磁性丝素蛋白基复合气凝胶、制备方法及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246282B2 (cg-RX-API-DMAC7.html) * 1972-11-15 1977-11-24
US4097234A (en) * 1976-12-10 1978-06-27 Nippi, Incorporated Method for preparing dispersion of collagen fiber
US4279812A (en) * 1979-09-12 1981-07-21 Seton Company Process for preparing macromolecular biologically active collagen
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
FR2720945B1 (fr) * 1994-06-08 1996-08-30 Coletica Membrane collagénique anti-adhérence post-opératoire.
US5945125A (en) 1995-02-28 1999-08-31 Temple University Controlled release tablet
AU716137B2 (en) * 1997-01-16 2000-02-17 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US20010014667A1 (en) * 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6682760B2 (en) * 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
US6726923B2 (en) * 2001-01-16 2004-04-27 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
JP2004099513A (ja) * 2002-09-09 2004-04-02 Toshiba Corp クラゲのコラーゲン回収方法及びクラゲのコラーゲン回収システム
US7396912B2 (en) * 2003-04-11 2008-07-08 Ecodynamic Biolab Collagen production method
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
TR201905174T4 (tr) * 2007-03-28 2019-05-21 Innocoll Pharm Ltd Lokal analjezi, lokal anestezi veya sinir blokajı sağlamak için bir ilaç iletim cihazı.
US8034368B2 (en) * 2007-03-28 2011-10-11 Innocoll Technologies Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
USRE47826E1 (en) * 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US7820794B2 (en) 2008-09-11 2010-10-26 Sunmax Biotechnology Co., Ltd. Long-lasting collagen and manufacturing method thereof
EP2352531A2 (en) * 2008-11-06 2011-08-10 Innocoll Technologies Limited Drug delivery implants and processes for their preparation
WO2011014155A1 (en) * 2009-07-27 2011-02-03 National Cheng Kung University Preparation of high purity collagen
JP2011225462A (ja) * 2010-04-16 2011-11-10 Ihara Suisan Kk 多孔質コラーゲン、その製造方法およびその用途
WO2011139228A1 (en) 2010-05-07 2011-11-10 Empire Technology Development Llc Nano scale collagen particles and membranes
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
HUE054838T2 (hu) * 2012-01-09 2021-10-28 Innocoll Pharm Ltd Módosított kollagén
US11623947B2 (en) * 2013-04-08 2023-04-11 Innocoll Pharmaceuticals Limited Collagen powder

Similar Documents

Publication Publication Date Title
JP2015508403A5 (cg-RX-API-DMAC7.html)
TN2014000356A1 (en) Heterocyclyl compounds as mek inhibitors
WO2013123215A3 (en) Antiviral drugs for treatment of arenavirus infection
EP4357355A3 (en) Virus purification
EP3928800A3 (en) Dry powder composition comprising long-chain rna
HK1204770A1 (en) Compartmentalized method of nucleic acid delivery and compositions and uses thereof
HRP20210699T1 (hr) Izmijenjeni kolagen
JP2013537212A5 (cg-RX-API-DMAC7.html)
JP2018512440A5 (cg-RX-API-DMAC7.html)
BR112013026153A2 (pt) Composição farmacêutica; uso de pelo menos um éter de celulose não iônico; método parapreparar uma composição farmacêutica; método para tratar e/ou prevenir um distúrbioclimatérico; uso de uma composição farmacêutica; e kit
WO2013177172A3 (en) Herpesvirus compositions and related methods
US10617649B2 (en) Preparation method of azacitidine for injection
CY1113885T1 (el) Μια ιατρικη κρεμα φουσιδικου οξεος που παρασκευαζεται με την χρηση φουσιδικου νατριου και ενσωματωση ενος βιοπολυμερους και μια μεθοδος για την παρασκευη της
WO2019025863A3 (en) MEDICAMENT COMPOUND AND METHODS OF PURIFICATION
ZA201906327B (en) Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
CN104188903A (zh) 奥硝唑注射液及其制备方法
WO2012103512A3 (en) Expanded utility of red cell-derived microparticles (rmp) for treatment of bleeding
JP2013542954A5 (cg-RX-API-DMAC7.html)
RU2019111152A (ru) Новый способ стабилизации биофармацевтического лекарственного продукта при производстве
CL2013000021A1 (es) Forma cristalina delta de la sal de arginina de perindoprilo; procedimiento de preparacion; composiciones farmaceuticas que la contienen; y su uso par el tratamiento de las enfermedades cardiovasculares, tales como hipertension arterial, insuficiencia cardiaca o enfermedad coronaria estable.
RU2012110454A (ru) Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в интерфероне
JP2015526463A5 (cg-RX-API-DMAC7.html)
RU2015137828A (ru) Стабильное и лиофилизированное фармацевтическое средство, содержащее нокатиацин
WO2015066664A3 (en) Compositions and methods for administration of an enzyme to a subject's airway
RU2016105242A (ru) Дермальная матрица и способ получения матрицы, которая имеет синергические эффекты содержания микроцастиц, которые обеспечивают заживление ткани